Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome?

Dermatol Ther. 2022 Jul;35(7):e15559. doi: 10.1111/dth.15559. Epub 2022 May 15.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Melanins
  • Melanoma* / drug therapy
  • Melanoma* / pathology
  • Nevus, Halo*
  • Nivolumab / therapeutic use
  • Skin Neoplasms* / drug therapy
  • Skin Neoplasms* / pathology

Substances

  • Melanins
  • Nivolumab